SAPCD2 could bind to E2F7 in the cytoplasm and thereby alter the subcellular distribution of E2F7, derepressing E2F signaling transactivation and promoting NB progression (Fig. 6). The gene discussed is SAPCD2; the disease is neuroblastoma.